Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multi-centric Castleman's Disease × pomalidomide × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 3 Acquired Immunodeficiency Syndrome 2 Sarcoma 1 Multi-centric Castleman's Disease 1

Interventions

tocilizumab 1 pomalidomide 1 liposomal doxorubicin 1 Zidovudine 1 Valganciclovir 1 Polymerase Chain Reaction 1 Histological Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02659930 2026-02-19

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡